Skip to main content

Table 2 Tumor antigen and HLA-class I expression in resected tumors

From: α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial

Patient hHLA-typing Tumor antigen expression HLA-class Ia
1 A*2402 N. D. N. D. b
2 A*2402 5/5 (M1, M3, HER2, gp100, WT-1) ++
3 A*2402 5/5 +
4 A*2402 N. D. N. D.
5 A*2402 3/5 (M3, HER2, WT-1) +
6 A*2402 5/5 +
7 A*0201 5/5 +
8 A*2402 N. D. N. D.
9 A*2402 5/5 +
  1. aHLA-class I expression was checked on IHC, b N. D. ; not done.